If additional glycemic control is needed after 30 days, the dose may be increased to 14mg a day
Mounjaro is the brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist that is licensed in the UK for certain uses, including weight management in eligible patients
The first, as Adams' experienced, is the "dam breaking phenomenon, which is what you'd expect from taking a ton of laxatives," Goldstein said
Its commonly prescribed off-label for weight loss, and theres another medication called Wegovy, which contains the same active ingredient, semaglutide, and is FDA-approved for chronic weight management
Correlation between glutathione plasma with degree severity of melasma in Balinese women